Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Professor of Matrix Biology Kim Midwood, of the Kennedy Institute of Rheumatology, NDORMS has been named in the BioBeat 2015 Movers and Shakers report.

The 2015 report recognises 50 inspirational women in biobusiness in the UK who are challenging the status quo to bring better health to people around the world. The annual BioBeat report highlights 50 inspirational female entrepreneurs, pioneers and advisors across the industry. 

Founded in 2012 by Miranda Weston-Smith, BioBeat aims to bring fresh energy and growth to the bio sector.  

Successful women entrepreneurs and leaders can support the rapid transformation of the global biobusiness sector, as research suggests they adopt different strategies for success which can lead to business models that more effectively engage talent in broader, more inclusive and more dynamic ways.

Professor Midwood's research focuses on how the cellular microenvironment defines the immune response. She uses a multidisciplinary approach incorporating structural, biochemical, molecular, proteomic and epigenetic tools to find new diagnostics and therapeutics to control inflammation. 

She founded the BioTech company Nascient Ltd in 2012 to develop new drugs for inhibiting chronic inflammation in diseases such as rheumatoid arthritis. She also has a long history of consulting for biotech companies. 

"I am delighted to be listed in the BioBeat report; it's a real honour to be recognised alongside all the women nominated who have had a tremendous impact in the Bio Tech world, and I hope that this report encourages more women to consider taking on a role in the BioBusiness sector", says Professor Midwood.

Visit 50 Movers and Shakers in BioBusiness 2015 for the full list.

Similar stories

Professor Michael Dustin appointed new Chair in Molecular Immunology

A generous gift from the Kennedy Trust for Rheumatology Research has enabled the creation of a new Chair in Molecular Immunology at the University of Oxford.

Two prestigious Hunterian Professorships awarded to NDORMS researchers

Conrad Harrison and Tom Layton have both been awarded Hunterian Professorships for 2022 by the Royal College of Surgeons of England

Dr Alex Clarke wins Emerging Leaders Prize for lupus research

Alex is one of three exceptional lupus researchers that have been announced as winners of the Medical Research Foundation’s sixth Emerging Leaders Prize.

Yoshi Itoh wins the International Dupuytren Award 2022

Yoshi Itoh, Associate Professor and Principal Investigator Cell Migration Group at the Kennedy Institute has been awarded the International Dupuytren Award 2022.

NDORMS researchers awarded Associate Professor title

The University of Oxford has awarded the title of Associate Professor to Adam Cribbs and Luke Jostins.

Fiona Powrie honoured by British Society for Immunology

Fiona Powrie was one of four researchers from the University of Oxford recognised for their outstanding contributions to immunology with Honorary Lifetime Membership of the British Society for Immunology.